Literature DB >> 20457872

High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations.

Yu-Chang Wu1, David Kipling, Hui Sun Leong, Victoria Martin, Alexander A Ademokun, Deborah K Dunn-Walters.   

Abstract

B-cell receptor (BCR) diversity is achieved centrally by rearrangement of Variable, Diversity, and Joining genes, and peripherally by somatic hypermutation and class-switching of the rearranged genes. Peripheral B-cell populations are subject to both negative and positive selection events in the course of their development that have the potential to shape the BCR repertoire. The origin of IgM(+)IgD(+)CD27(+) (IgM memory) cells is controversial. It has been suggested that they may be a prediversified, antigen-independent, population of cells or that they are a population of cells that develop in response to T-independent antigens. Most recently, it was suggested that the majority of IgM memory cells are directly related to switched memory cells and are early emigrants from the germinal center reaction. Advances in sequencing technology have enabled us to undertake large scale IGH repertoire analysis of transitional, naive, IgM memory and switched memory B-cell populations. We find that the memory B-cell repertoires differ from the transitional and naive repertoires, and that the IgM memory repertoire is distinct from that of class-switched memory. Thus we conclude that a large proportion of IgM memory cells develop in response to different stimuli than for class-switched memory cell development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20457872      PMCID: PMC2938129          DOI: 10.1182/blood-2010-03-275859

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  41 in total

1.  Molecular structure of eight human autoreactive monoclonal antibodies.

Authors:  I Aguilera; J Melero; A Nuñez-Roldan; B Sanchez
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

2.  Third complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, P, and N components than non-mutated genes.

Authors:  K Rosner; D B Winter; R E Tarone; G L Skovgaard; V A Bohr; P J Gearhart
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

3.  Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma.

Authors:  Delin Zhu; Helen McCarthy; Christian H Ottensmeier; Peter Johnson; Terry J Hamblin; Freda K Stevenson
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

4.  Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells.

Authors:  Hirochika Toyama; Seiji Okada; Masahiko Hatano; Yoshimasa Takahashi; Nobue Takeda; Hirohito Ichii; Toshitada Takemori; Yoshikazu Kuroda; Takeshi Tokuhisa
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

5.  CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans.

Authors:  S Weller; A Faili; C Garcia; M C Braun; F Le Deist F; G de Saint Basile G; O Hermine; A Fischer; C A Reynaud; J C Weill
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

6.  Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant.

Authors:  Eva Gärdby; Jens Wrammert; Karin Schön; Lena Ekman; Tomas Leanderson; Nils Lycke
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

7.  Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers.

Authors:  Kai-Michael Toellner; William E Jenkinson; Dale R Taylor; Mahmood Khan; Daniel M-Y Sze; David M Sansom; Carola G Vinuesa; Ian C M MacLennan
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

8.  Germinal centers without T cells.

Authors:  C G de Vinuesa; M C Cook; J Ball; M Drew; Y Sunners; M Cascalho; M Wabl; G G Klaus; I C MacLennan
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

9.  Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen.

Authors:  Stephanie Kruetzmann; M Manuela Rosado; Holger Weber; Ulrich Germing; Olivier Tournilhac; Hans-Hartmut Peter; Reinhard Berner; Anke Peters; Thomas Boehm; Alessandro Plebani; Isabella Quinti; Rita Carsetti
Journal:  J Exp Med       Date:  2003-04-07       Impact factor: 14.307

10.  Activation-induced deaminase (AID)-directed hypermutation in the immunoglobulin Smu region: implication of AID involvement in a common step of class switch recombination and somatic hypermutation.

Authors:  Hitoshi Nagaoka; Masamichi Muramatsu; Namiko Yamamura; Kazuo Kinoshita; Tasuku Honjo
Journal:  J Exp Med       Date:  2002-02-18       Impact factor: 14.307

View more
  142 in total

1.  Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Mitch Phillips; Nicholas V Mendez; Ana Marie Landin; Bonnie B Blomberg
Journal:  Int Immunol       Date:  2012-01-25       Impact factor: 4.823

Review 2.  New tools for classification and monitoring of autoimmune diseases.

Authors:  Holden T Maecker; Tamsin M Lindstrom; William H Robinson; Paul J Utz; Matthew Hale; Scott D Boyd; Shai S Shen-Orr; C Garrison Fathman
Journal:  Nat Rev Rheumatol       Date:  2012-05-31       Impact factor: 20.543

3.  Complexity of the human memory B-cell compartment is determined by the versatility of clonal diversification in germinal centers.

Authors:  Bettina Budeus; Stefanie Schweigle de Reynoso; Martina Przekopowitz; Daniel Hoffmann; Marc Seifert; Ralf Küppers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

4.  Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing.

Authors:  Jason A Vander Heiden; Panos Stathopoulos; Julian Q Zhou; Luan Chen; Tamara J Gilbert; Christopher R Bolen; Richard J Barohn; Mazen M Dimachkie; Emma Ciafaloni; Teresa J Broering; Francois Vigneault; Richard J Nowak; Steven H Kleinstein; Kevin C O'Connor
Journal:  J Immunol       Date:  2017-01-13       Impact factor: 5.422

Review 5.  Human lymphocyte repertoires in ageing.

Authors:  Scott D Boyd; Yi Liu; Chen Wang; Victoria Martin; Deborah K Dunn-Walters
Journal:  Curr Opin Immunol       Date:  2013-08-28       Impact factor: 7.486

6.  Comparative study of IgA VH 3 gene usage in healthy TST(-) and TST(+) population exposed to tuberculosis: deep sequencing analysis.

Authors:  Siang Tean Chin; Joshua Ignatius; Siti Suraiya; Gee Jun Tye; Maria E Sarmiento; Armando Acosta; Mohd Nor Norazmi; Theam Soon Lim
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

7.  B cell variable genes have evolved their codon usage to focus the targeted patterns of somatic mutation on the complementarity determining regions.

Authors:  Jasmine Saini; Uri Hershberg
Journal:  Mol Immunol       Date:  2015-02-06       Impact factor: 4.407

Review 8.  Old questions, new tools: does next-generation sequencing hold the key to unraveling intestinal B-cell responses?

Authors:  O Pabst; H Hazanov; R Mehr
Journal:  Mucosal Immunol       Date:  2014-11-12       Impact factor: 7.313

9.  Human rotavirus-specific IgM Memory B cells have differential cloning efficiencies and switch capacities and play a role in antiviral immunity in vivo.

Authors:  Carlos F Narváez; Ningguo Feng; Camilo Vásquez; Adrish Sen; Juana Angel; Harry B Greenberg; Manuel A Franco
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

10.  De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.

Authors:  Hamid Mattoo; Vinay S Mahajan; Emanuel Della-Torre; Yurie Sekigami; Mollie Carruthers; Zachary S Wallace; Vikram Deshpande; John H Stone; Shiv Pillai
Journal:  J Allergy Clin Immunol       Date:  2014-05-06       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.